Low Molecular Weight Fucoidan Inhibits Pulmonary Fibrosis In Vivo and In Vitro via Antioxidant Activity

Figure 3

Assessment of pulmonary fibrosis. Immunohistochemical detection of fibrosis biomarkers: (a) collagen-1, (b) α-SMA, (c) fibronectin, and (d) TGF-β; (e) statistical expressions of fibrosis biomarkers by an immunohistochemical assay ( vs. the PF group; ^## vs. the Sham group); (f, g) hydroxyproline in the BALF and lung ( vs. the PF group; ^## vs. the Sham group); (h) expression of fibrosis biomarkers tested by Western blot; (i) statistical expressions of fibrosis biomarkers in by Western blot ( and vs. the PF group; ^# and ^## vs. the Sham group).

(a)

(b)

(c)

(d)

(e)

(f)

(g)

(h)

(i)